Iodcyclononan | 90948-93-9

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机碘化物
• 英文名称: Iodcyclononan
• 英文别名: iodo-cyclononane；Jod-cyclononan；Iodocyclononane
• CAS: 90948-93-9
• 化学式: C₉H₁₇I
• 分子量: 252.138
• InChiKey: GPVJSUKBEBRVRG-UHFFFAOYSA-N

物化性质

• 沸点：
  255.6±9.0 °C(Predicted)
• 密度：
  1.40±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  Iodcyclononan 在 甲醇 、 氢氧化钾 、 镍 作用下， 生成 环壬烷
  参考文献：
  名称：

  要知道碳环。（第37部分）。关于由相应的酮生产聚亚甲基烃

  摘要：

  DOI：

  10.1002/hlca.660280152
• 作为产物：
  描述：

  环壬n醇 在 氢碘酸 作用下， 生成 Iodcyclononan
  参考文献：
  名称：

  要知道碳环。（第37部分）。关于由相应的酮生产聚亚甲基烃

  摘要：

  DOI：

  10.1002/hlca.660280152

文献信息

• Remedy for Diabetes
  申请人：Suzuki Nobuhiro

  公开号：US20080319077A1

  公开（公告）日：2008-12-25

  The present invention relates to a therapeutic agent for diabetes with sulfonylurea secondary failure, which contains a GPR40 agonist. According to the present invention, a therapeutic agent for diabetes with sulfonylurea secondary failure that affords a superior insulin secretion effect and a superior hypoglycemic effect even in diabetic patients for whom a sulfonylurea compound or a fast-acting insulin secretagogue fails to provide an insulin secretion effect and therefore, fails to provide a sufficient hypoglycemic effect can be provided.

  本发明涉及一种含有GPR40激动剂的治疗糖尿病二甲基磺酰脲失效的药物。根据本发明，可以提供一种治疗糖尿病二甲基磺酰脲失效的药物，即使在糖尿病患者中，磺酰脲化合物或快速作用的胰岛素分泌剂无法提供胰岛素分泌效果，因此无法提供足够的降血糖效果，本药物也能提供卓越的胰岛素分泌效果和卓越的降血糖效果。
• Disease detection system and method
  申请人：Guzman Norberto A.

  公开号：US20100213062A1

  公开（公告）日：2010-08-26

  A disease detection system which includes an electrophoresis apparatus and a biomarker detector. The apparatus includes: (a) a transport passage; (b) a plurality of separation passages, each of the separation passages having an overlapping portion that overlaps the transport passage; and (c) a different biomarker concentrator in each of the overlapping portions and which concentrates at least one different biomarker from a specimen from an animal introduced into the transport passage. A plurality of the different biomarkers is associated with at least one predetermined disease, such as diabetes, heart disease or cancer. The detector detects the presence of the different biomarkers which were concentrated by the biomarker concentrators and delivered to the biomarker detector via the separation passages. First and second sets of the biomarker concentrators can be associated with respective first and second predetermined diseases and the user can determine which set will be used in each procedure.
• METHOD FOR IMMOBILIZING NUCLEIC ACIDS ON A SUPPORT
  申请人：Pierik Anke

  公开号：US20110319275A1

  公开（公告）日：2011-12-29

  The present invention relates to a method for immobilizing nucleic acids on a support, comprising the provision of a nucleic acid with a stretch of nucleotides of only one basetype and the immobilization of said nucleic acid on a support by crosslinking by light, wherein said crosslinking by light is performed at a wavelength of about 300-500 nm, preferably at a wavelength of 365 nm. The present invention further relates to a method for the analysis of nucleic acids immobilized according to the invention, which comprises the hybridization of the immobilized nucleic acid with complementary and mismatch segments. Furthermore, the present invention relates to immobilized nucleic acids obtainable by the method of the invention, the use of accordingly immobilized nucleic acids for the production of nucleic acid arrays and a diagnostic kit, comprising an array of nucleic acids which are immobilized according to the present invention.
• US5968868A
  申请人：——

  公开号：US5968868A

  公开（公告）日：1999-10-19
• US7932289B2
  申请人：——

  公开号：US7932289B2

  公开（公告）日：2011-04-26